The DOI matches its Crossref record.
Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
Abstract
The survival of microencapsulated islet grafts is limited, even if capsular overgrowth is restricted to a small percentage of the capsules. In search of processes other than overgrowth contributing to graft failure, we have studied the islets in non-overgrown capsules at several time points after allotransplantation in the rat. All recipients of islet allografts became normoglycemic. Grafts were retrieved at 4 and 8 weeks after implantation and at 15.3 +/- 2.3 weeks postimplant, 2 weeks after the mean time period at which graft failure occurred. Overgrowth of capsules was complete within 4 weeks postimplant, and it was usually restricted to <10% of the capsules. During the first 4 weeks of implantation, 40% of the initial number of islets was lost. Thereafter, we observed a decrease in function rather than in numbers of islets, as illustrated by a decline in the ex vivo glucose-induced insulin response. At 4 and 8 weeks postimplant, beta-cell replication was 10-fold higher in encapsulated islets than in islets in the normal pancreas, but these high replication rates were insufficient to prevent a progressive increase in the percentage of nonviable tissue in the islets. Necrosis and not apoptosis proved to be the major cause of cell death in the islets. The necrosis mainly occurred in the center of the islets, which indicates insufficient nutrition as a major causative factor. Our study demonstrates that not only capsular overgrowth but also an imbalance between beta-cell birth and beta-cell death contributes to the failure of encapsulated islet grafts. Our observations indicate that we should focus on finding or creating a transplantation site that, more than the unmodified peritoneal cavity, permits for close contact between the blood and the encapsulated islet tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Technology of mammalian cell encapsulation
Uludag, H., De Vos, P., & Tresco, P. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00053-3 · Cited by 601
Self-citationAlginate-based microcapsules for immunoisolation of pancreatic islets
de Vos, P., Faas, M. M., Strand, B., & Calafiore, R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.010 · Cited by 511
Self-citationPolymers in cell encapsulation from an enveloped cell perspective
de Vos, P., Lazarjani, H. A., Poncelet, D., & Faas, M. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.005 · Cited by 298
Self-citationDuvivier-Kali, V. F., Omer, A., Parent, R. J., O’Neil, J. J., & Weir, G. C. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1698 · Cited by 291
Considerations for successful transplantation of encapsulated pancreatic islets
de Vos, P., Hamel, A. F., & Tatarkiewicz, K. (2002) · Diabetologia · doi:10.1007/s00125-001-0729-x · Cited by 252
Self-citation
Metadata
- Authors
- De Vos, P., Van Straaten, J. F., Nieuwenhuizen, A. G., de Groot, M., Ploeg, R. J., De Haan, B. J., & Van Schilfgaarde, R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1999-07-01
- Volume
- 48
- Issue
- 7
- Pages
- 1381-1388
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2098899709
- Cited by
- 201
- References
- 0
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? https://app.cochat.ai/papers/10.2337/diabetes.48.7.1381
- The paper
- De Vos, P., Van Straaten, J. F., Nieuwenhuizen, A. G., de Groot, M., Ploeg, R. J., De Haan, B. J., & Van Schilfgaarde, R. (1999). Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes. https://doi.org/10.2337/diabetes.48.7.1381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.